It accelerates blood vessel formation (angiogenesis), modulates inflammatory pathways, and enhances collagen synthesis, all of which are crucial for tissue recovery
Semaglutide in patients with obesity-related heart failure and type 2 diabetes
T., Milliner, D
PTD-DBM addresses a structural signaling problem rather than providing temporary growth factor supplementation
The safety profile supports consistent long-term daily use, and the collagen-stimulating effects are cumulative, meaning uninterrupted use produces better results than starting and stopping
Pharmacodynamic Effects and Duration Despite measurable plasma clearance, pharmacodynamic effects extend well beyond plasma half-life[20]: Weight loss effects continue throughout treatment with no plateau observed within 48-week study periods Glycemic improvements persist between weekly doses with stable glucose control Appetite suppression effects remain consistent throughout dosing intervals Tissue receptor occupancy likely exceeds plasma peptide concentrations This disconnect between pharmacokinetics and pharmacodynamics suggests prolonged receptor engagement, tissue depot effects, or persistent downstream signaling cascade activation